“…All have limitations on the adequacy and length of protection (43), and their protective effects are dependent on the conditions of the study (19,21,31). Many of the heart studies compare one preservation solution to another (5,8,16,20,21,24,25,30,33,35,(52)(53)(54) and with or without additives, such as channel activators or blockers (11,12,18,26,40,44,46), ion exchange inhibitors (6,42,48), anesthetics (2,40,47), or BDM (20,46,49). For example, Celsior preserved function better than ViaSpan in several studies (29,52), whereas ViaSpan was better than Celsior in others (5,20).…”